Nukkleus Inc. (DFNS)

Data as of Apr 28, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch DFNS

See up to 3 months of DFNS. The 7-day demo opens the 1M and 3M ranges and puts DFNS on your watchlist.

Latest DFNS insider trades

Anastasiia Kotaieva
Open-market sale$132K
Dec 22, 2025
Anastasiia Kotaieva
Open-market sale$320K
Dec 23, 2025
Anastasiia Kotaieva
Open-market sale

About Nukkleus Inc. (DFNS)

Nukkleus Inc. is an SEC registrant, filing under CIK 0001787518, classified as management consulting services. It is grouped with Industrials companies on this site. A registration statement was filed on 17 December 2025. No offering has priced.

Sector: Industrials

SEC filings for DFNS on EDGAR

DFNS Form 4 activity by transaction type, last 90 days

No Form 4 activity for DFNS in the last 90 days.

DFNS insider transactions (Form 4)

17 Form 4 filings on record, the earliest from Dec 20, 2024, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Apr 27, 2026	Menachem Shalom - Officer	Other	Common Stock	4,174,399	$0.51	$2.14M
Apr 27, 2026	Menachem Shalom - Officer	Other	Common Stock	67,009	-^{footnote F2}	-
Apr 27, 2026	Menachem Shalom - Officer	Other	Stock Purchase Warrant	2,357,303	-^{footnote F2}	-
Footnote F2 (price): On April 27, 2026, the Reporting Person acquired 67,009 shares of Common Stock and 2,357,303 warrants upon the exercise of the option granted to him from Esousa Group Holdings LLC.
Jan 29, 2026	Menachem Shalom - Officer	Other	Common Stock $0.0001 par value per share	200,000	$1.50^{footnote F1}	$300K
Jan 29, 2026	Menachem Shalom - Officer	Other	Common Stock Purchase Warrants	200,000	$1.50^{footnote F1}	$300K
Footnote F1 (price): The Reporting Person exercised a warrant for Cash to purchase 200,000 restricted shares of the Issuer's common stock at an exercise price of $1.50 per share.
Jan 16, 2026	Menachem Shalom - Officer	Other	Common Stock$0.0001 par value per share	1,992,010	$0.00^{footnote F1}	-
Jan 15, 2026	Menachem Shalom - Officer	Other	Common Stock Purchase Warrants	5,018,359	$0.00^{footnote F1}	-
Jan 13, 2026	Menachem Shalom - Officer	Grant or award	Call Option (to Purchase Common Stock and warrants)	1,752,593	-^{footnote F2}	-
Footnote F1 (price): The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the… Full note on SEC EDGAR Footnote F2 (price): The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of… Full note on SEC EDGAR
Dec 22, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	30,000	$4.41	$132K
Dec 23, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	70,000	$4.57	$320K
Dec 24, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	55,604	$4.49	$250K
Dec 26, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	55,604	$4.26	$237K
Dec 18, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	38,744	$4.72^{footnote F1}	$183K
Dec 19, 2025	Anastasiia Kotaieva	Open-market sale	Common Stock, $0.0001 par value per share	70,000	$4.53^{footnote F3}	$317K
Footnote F1 (price): The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $5.01 to $4.67, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and… Full note on SEC EDGAR Footnote F3 (price): The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.695 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and… Full note on SEC EDGAR
Nov 13, 2025	Tomer Nagar - Director	Grant or award	Common Stock, $0.0001 par value per share	5,000	$0.00^{footnote F1}	-
Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
Nov 13, 2025	Reuven Yeganeh - Director	Grant or award	Common Stock, $0.0001 par value per share	10,000	$0.00^{footnote F1}	-
Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
Nov 13, 2025	David Rokach - Director	Grant or award	Common Stock, $0.0001 par value per share	5,000	$0.00^{footnote F1}	-
Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
Nov 13, 2025	Aviya Volodarsky - Director	Grant or award	Common Stock, $0.0001 par value per share	5,000	$0.00^{footnote F1}	-
Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
Nov 13, 2025	Menachem Shalom - Officer	Grant or award	Common Stock, $0.0001 par value per share	750,000	$0.00^{footnote F1}	-
Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
Oct 24, 2025	Anastasiia Kotaieva - Director	Gift	Common Stock, $0.0001 par value per share	377,432	$0.00	-
Oct 8, 2025	Anastasiia Kotaieva - Director	Open-market purchase	Common Stock, $0.0001 par value per share	117,568	-^{footnote F1}	-
Oct 9, 2025	Anastasiia Kotaieva - Director	Open-market purchase	Common Stock, $0.0001 par value per share	259,864	-^{footnote F2}	-
Oct 9, 2025	Anastasiia Kotaieva - Director	Open-market purchase	Common Stock, $0.0001 par value per share	999,989	-^{footnote F3}	-
Oct 7, 2025	Anastasiia Kotaieva - Director	Open-market purchase	Warrant	1,000,000	$0.00	$100
Oct 8, 2025	Anastasiia Kotaieva - Director	Other	Warrant	150,000	-^{footnote F1}	-
Oct 9, 2025	Anastasiia Kotaieva - Director	Other	Warrant	351,424	-^{footnote F2}	-
Oct 9, 2025	Anastasiia Kotaieva - Director	Other	Warrant	1,000,000	-^{footnote F3}	-
Footnote F1 (price): Shares issued upon exercise (on a cashless basis) of a warrant issued in June 2024 to X Group Family of Funds Limited Partnership for 150,000 shares (after giving effect to a reverse split implemented in October 2024). Anastasiia Kotaieva, a director of the Company, is the owner… Full note on SEC EDGAR Footnote F2 (price): Shares issued upon exercise (on a cashless basis) of a warrant issued in November 2024 to X Group Family of Funds Limited Partnership for 351,424 shares. Anastasiia Kotaieva, a director of the Company, is the owner of X Group Family of Funds Limited Partnership. Footnote F3 (price): Shares issued upon exercise (on a cashless basis) of a pre-funded warrant issued in August 2025 to an unrelated third party for a total of 1,702,088 shares and assigned on October 7, 2025 to X Group Family of Funds Limited Partnership. Anastasiia Kotaieva, a director of the… Full note on SEC EDGAR
Dec 16, 2024	Anastasiia Kotaieva - Officer	Grant or award	Common Stock, $0.0001 par value per share	500,000	$1.39	$695K
Nov 8, 2024	Anastasiia Kotaieva - Officer	Open-market purchase	Common Stock, $0.0001 par value per share	319,952	$2.41	$771K
Nov 8, 2024	Anastasiia Kotaieva - Officer	Open-market purchase	Warrant	351,424	$2.41	$847K
Dec 16, 2024	David Rokach - Officer	Grant or award	Common Stock, $0.0001 par value per share	10,000	$1.39	$14K
Dec 16, 2024	Menachem Shalom - Officer	Grant or award	Common Stock, $0.0001 par value per share	500,000	$1.39	$695K
Dec 16, 2024	Aviya Volodarsky - Officer	Grant or award	Common Stock, $0.0001 par value per share	10,000	$1.39	$14K
Dec 16, 2024	Reuven Yeganeh - Officer	Grant or award	Common Stock, $0.0001 par value per share	10,000	$1.39	$14K

Recent DFNS Form 8-K filings

Read DFNS company news

Oct 7, 2026Item 5.02, 9.01

Read the filing on SEC EDGAR

Sep 11, 2026Item 2.03, 9.01

Read the filing on SEC EDGAR

Sep 10, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Aug 31, 2026Item 1.02, 8.01, 9.01

DFNS insider trading FAQ

What is the latest insider trade for DFNS?

Nukkleus Inc. (DFNS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-28. The full record for DFNS runs to 17 Form 4 filings, the earliest from 2024-12-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying DFNS stock?

No insider purchases of DFNS were filed in the last 90 days. 6 purchases are on record for this company.

How many insiders are selling DFNS stock?

No insider sales of DFNS were filed in the last 90 days. 6 sales are on record for this company.

Where can I see DFNS SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects DFNS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Industrials companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Apr 28, 2026 - Menachem Shalom view on EDGAR
Jan 29, 2026 - Menachem Shalom view on EDGAR
Jan 21, 2026 - Menachem Shalom view on EDGAR
Dec 31, 2025 - Anastasiia Kotaieva view on EDGAR
Dec 22, 2025 - Anastasiia Kotaieva view on EDGAR
Nov 20, 2025 - Tomer Nagar view on EDGAR
Nov 20, 2025 - Reuven Yeganeh view on EDGAR
Nov 20, 2025 - David Rokach view on EDGAR
Nov 20, 2025 - Aviya Volodarsky view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Industrials: Where DFNS's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow DFNS with a 7-day demo

DFNS on your watchlist
Every DFNS Form 4 filing on record
Up to 3 months of DFNS price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Apr 27, 2026

Menachem Shalom - Officer

Other

Common Stock

4,174,399

$0.51

$2.14M

Apr 27, 2026

Menachem Shalom - Officer

Other

Common Stock

67,009

-^{footnote F2}

Apr 27, 2026

Menachem Shalom - Officer

Other

Stock Purchase Warrant

2,357,303

-^{footnote F2}

Footnote F2 (price): On April 27, 2026, the Reporting Person acquired 67,009 shares of Common Stock and 2,357,303 warrants upon the exercise of the option granted to him from Esousa Group Holdings LLC.

Jan 29, 2026

Menachem Shalom - Officer

Other

Common Stock $0.0001 par value per share

200,000

$1.50^{footnote F1}

$300K

Jan 29, 2026

Menachem Shalom - Officer

Other

Common Stock Purchase Warrants

200,000

$1.50^{footnote F1}

$300K

Footnote F1 (price): The Reporting Person exercised a warrant for Cash to purchase 200,000 restricted shares of the Issuer's common stock at an exercise price of $1.50 per share.

Jan 16, 2026

Menachem Shalom - Officer

Other

Common Stock$0.0001 par value per share

1,992,010

$0.00^{footnote F1}

Jan 15, 2026

Menachem Shalom - Officer

Other

Common Stock Purchase Warrants

5,018,359

$0.00^{footnote F1}

Jan 13, 2026

Menachem Shalom - Officer

Grant or award

Call Option (to Purchase Common Stock and warrants)

1,752,593

-^{footnote F2}

Footnote F1 (price): The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the… Full note on SEC EDGAR
Footnote F2 (price): The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of… Full note on SEC EDGAR

Dec 22, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

30,000

$4.41

$132K

Dec 23, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

70,000

$4.57

$320K

Dec 24, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

55,604

$4.49

$250K

Dec 26, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

55,604

$4.26

$237K

Dec 18, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

38,744

$4.72^{footnote F1}

$183K

Dec 19, 2025

Anastasiia Kotaieva

Open-market sale

Common Stock, $0.0001 par value per share

70,000

$4.53^{footnote F3}

$317K

Footnote F1 (price): The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $5.01 to $4.67, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and… Full note on SEC EDGAR
Footnote F3 (price): The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.695 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and… Full note on SEC EDGAR

Nov 13, 2025

Tomer Nagar - Director

Grant or award

Common Stock, $0.0001 par value per share

5,000

$0.00^{footnote F1}

Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

Nov 13, 2025

Reuven Yeganeh - Director

Grant or award

Common Stock, $0.0001 par value per share

10,000

$0.00^{footnote F1}

Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

Nov 13, 2025

David Rokach - Director

Grant or award

Common Stock, $0.0001 par value per share

5,000

$0.00^{footnote F1}

Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

Nov 13, 2025

Aviya Volodarsky - Director

Grant or award

Common Stock, $0.0001 par value per share

5,000

$0.00^{footnote F1}

Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

Nov 13, 2025

Menachem Shalom - Officer

Grant or award

Common Stock, $0.0001 par value per share

750,000

$0.00^{footnote F1}

Footnote F1 (price): The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

Oct 24, 2025

Anastasiia Kotaieva - Director

Gift

Common Stock, $0.0001 par value per share

377,432

$0.00

Oct 8, 2025

Anastasiia Kotaieva - Director

Open-market purchase

Common Stock, $0.0001 par value per share

117,568

-^{footnote F1}

Oct 9, 2025

Anastasiia Kotaieva - Director

Open-market purchase

Common Stock, $0.0001 par value per share

259,864

-^{footnote F2}

Oct 9, 2025

Anastasiia Kotaieva - Director

Open-market purchase

Common Stock, $0.0001 par value per share

999,989

-^{footnote F3}

Oct 7, 2025

Anastasiia Kotaieva - Director

Open-market purchase

Warrant

1,000,000

$0.00

$100

Oct 8, 2025

Anastasiia Kotaieva - Director

Other

Warrant

150,000

-^{footnote F1}

Oct 9, 2025

Anastasiia Kotaieva - Director

Other

Warrant

351,424

-^{footnote F2}

Oct 9, 2025

Anastasiia Kotaieva - Director

Other

Warrant

1,000,000

-^{footnote F3}

Footnote F1 (price): Shares issued upon exercise (on a cashless basis) of a warrant issued in June 2024 to X Group Family of Funds Limited Partnership for 150,000 shares (after giving effect to a reverse split implemented in October 2024). Anastasiia Kotaieva, a director of the Company, is the owner… Full note on SEC EDGAR
Footnote F2 (price): Shares issued upon exercise (on a cashless basis) of a warrant issued in November 2024 to X Group Family of Funds Limited Partnership for 351,424 shares. Anastasiia Kotaieva, a director of the Company, is the owner of X Group Family of Funds Limited Partnership.
Footnote F3 (price): Shares issued upon exercise (on a cashless basis) of a pre-funded warrant issued in August 2025 to an unrelated third party for a total of 1,702,088 shares and assigned on October 7, 2025 to X Group Family of Funds Limited Partnership. Anastasiia Kotaieva, a director of the… Full note on SEC EDGAR

Dec 16, 2024

Anastasiia Kotaieva - Officer

Grant or award

Common Stock, $0.0001 par value per share

500,000

$1.39

$695K

Nov 8, 2024

Anastasiia Kotaieva - Officer

Open-market purchase

Common Stock, $0.0001 par value per share

319,952

$2.41

$771K

Nov 8, 2024

Anastasiia Kotaieva - Officer

Open-market purchase

Warrant

351,424

$2.41

$847K

Dec 16, 2024

David Rokach - Officer

Grant or award

Common Stock, $0.0001 par value per share

10,000

$1.39

$14K

Dec 16, 2024

Menachem Shalom - Officer

Grant or award

Common Stock, $0.0001 par value per share

500,000

$1.39

$695K

Dec 16, 2024

Aviya Volodarsky - Officer

Grant or award

Common Stock, $0.0001 par value per share

10,000

$1.39

$14K

Dec 16, 2024

Reuven Yeganeh - Officer

Grant or award

Common Stock, $0.0001 par value per share

10,000

$1.39

$14K